HIV-related neurocognitive impairment in the HAART era

ArticleinCurrent HIV/AIDS Reports 6(3):146-52 · September 2009with5 Reads
Impact Factor: 3.80 · DOI: 10.1007/s11904-009-0020-1 · Source: PubMed

    Abstract

    Neurocognitive impairment is common in people living with HIV and AIDS. Prior to highly active antiretroviral therapy (HAART), cognitive impairment primarily affected patients with advanced disease, and was a more rapidly progressive illness. With the use of HAART, cognitive impairment improved, along with the overall health of HIV-positive patients. However, it is still a prevalent problem, even in patients with desirable CD4+ count and undetectable plasma viral load. In this review, we address the nature of HIV-related neurocognitive impairment in the HAART era, including its etiology, pathology, appropriate diagnostic tools for clinical practice and research, and rational treatment approaches.